This scientific work approaches the views and the latest data on the treatment of peritoneal metastasis. Its framework is composed of established and proven knowledge presented systematically. The content covers the entire range of requirements for a book on such a specialized topic.

The author, Mr. Ioannis Spiliotis, with his extensive experience and remarkable work in surgical oncology, contributes greatly to the analysis of the subject. Greek surgeons who specialize in peritoneal surface malignancy and have been trained in a program of the European School of Peritoneal Surface Malignancy also participate in the writing.

The purpose of the work is to inform the oncology community about the application of cytoreductive surgery and Hipec in strictly selected patients.

Some of the chapters of the book, which is divided into a general and a specific part, address the following topics:
- Pathophysiology of peritoneal metastasis
- Prognostic factors of peritoneal malignancy
- Cytoreductive surgery
- Mesothelioma of the peritoneum
- Peritoneal disease from gastric cancer
- Peritoneal metastasis from ovarian cancer
- Peritoneal metastasis from rare tumors
- Systemic chemotherapy in peritoneal metastasis
- Rules and safety measures during the application of intraoperative hyperthermic chemotherapy
- Locoregional therapies - Dosage and type of drugs
- and other topics

Cancer has become a "unique" entity and deserves to have its own trained personnel in the basic sciences, radiology, pharmacology, and surgery, as well as supportive nursing staff and other healthcare professionals. The collaboration of peritoneal oncologists on a regular basis and the exchange of the latest data are also important.